LACOG - Latin America Cooperative Oncology Group

Clinical and biological characterization of male breast cancer: an international EORTC, BIG, TBCRC and NABCG intergroup study.

Prospective evaluation of breast cancer at Brazilian institutions - Project AMAZONA III

A STUDY TO OBSERVE PATIENTS CHARACTERISTICS, TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED BREAST CANCER IN LATIN AMERICA - LACOG 0615 - LATINA Breast

Prospective evaluation of patients with uterine cervical cancer in Brazilian health institutions - The EVITA I study

Phase II randomized study of Abiraterone acetate plus ADT versus APALUTAMIDE versus Abiraterone and APALUTAMIDE in patients with advanced prostate cancer with non-castrate testosterone levels

Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN)

Multicenter database of patients with germ cell tumor in order of a clinicopathological characterization and evaluation of cancer treatment outcomes.

Validation of 99mTc- EDDA - HYNIC -TOC kits for diagnosis of neuroendocrine tumors

A randomized open-label, phase II study of lapatinib/capecitabine or lapatinib/vinorelbine or lapatinib/gemcitabine in subjects with Her2/neu amplified metastatic breast cancer patients progressing after taxanes treatment.

MGH - Internacional Breast Cancer Collaborative Project: Determination of a Endocrine Responsive Metastatic Breast Cancer Signature.

Metastatic cancer in Brazil: characterization of patients and treatments.

Evaluation of the attitude of premenopausal patients with breast cancer to the risk of loss of fertility caused by chemotherapy

A Phase II Randomized, Double-Blind, Parallel Cohort Study of Neoadjuvant Letrozole + GDC-0032 versus Letrozole + Placebo in Post-Menopausal Women with ER+/HER2- Primary Breast Cancer

PALLAS: PALbociclib CoLlaborative Adjuvant Study:
A randomized phase III trialof palbociclib with adjuvant endocrine
therapy versus endocrine therapy alone for hormone receptor positive
(HR+)/ human epidermal growth factor receptor 2 (HER2)-negative
early breast Cancer

A clinical and epidemiologic study of EML4-ALK and other ALK fusions genes in lung cancer patients in Latin American.

Use of [18]F-FDG - PET/CT in Brazil Unified Health System (SUS) as an alternative non-invasive method for staging of lung cancer.

Non-small-cell lung cancer (NSCLC) stage III treated with concurrent chemoradiation followed or not by consolidation chemotherapy.

A phase 3, double-blind randomized study to compare the efficacy and safety of rituximab plus lenalidomide (CC-5013) versus rituximab plus placebo in subjucts with relapsed/refractory indolent lymphoma.